Cuproptosis-related signature for clinical prognosis and immunotherapy sensitivity in hepatocellular carcinoma

ConclusionsOur findings highlight the potential of the CRGs risk score as an independent and promising biomarker for clinical prognosis and immunotherapy sensitivity in HCC patients.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research